# The Clinical Spectrum of Hypophosphatasia in Older Adults

**Authors:** Estefania Valdez Navarro, Evelyn M. Wong, Lianne Tile, Angela M. Cheung

PMC · DOI: 10.1002/ccr3.70920 · 2025-10-30

## TL;DR

This paper discusses the importance of diagnosing hypophosphatasia in older adults to avoid inappropriate osteoporosis treatments.

## Contribution

It emphasizes measuring alkaline phosphatase in older adults with fragility fractures to identify hypophosphatasia.

## Key findings

- Low serum alkaline phosphatase levels may indicate hypophosphatasia in older adults with fragility fractures.
- Correct diagnosis of HPP prevents the use of contraindicated antiresorptive medications.

## Abstract

Alkaline phosphatase (ALP) should be measured in older adults presenting with fragility fractures. Hypophosphatasia (HPP) should be suspected in individuals with hypophosphatasemia (low serum ALP). A correct diagnosis allows clinicians to avoid using potent antiresorptive osteoporosis medications, which are contraindicated in patients with HPP.

## Linked entities

- **Proteins:** ALPP (alkaline phosphatase, placental)
- **Diseases:** Hypophosphatasia (MONDO:0018570), osteoporosis (MONDO:0005298)

## Full-text entities

- **Genes:** ALPP (alkaline phosphatase, placental) [NCBI Gene 250] {aka ALP, PALP, PLAP, PLAP-1}
- **Diseases:** osteoporosis (MESH:D010024), fragility fractures (MESH:D005600), HPP (MESH:D007014)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12575442/full.md

---
Source: https://tomesphere.com/paper/PMC12575442